5//SEC Filing
LAROCHE RICHARD F JR 5
Accession 0001437749-23-012623
CIK 0001047335other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:16 PM ET
Size
14.6 KB
Accession
0001437749-23-012623
Insider Transaction Report
Form 5
LAROCHE RICHARD F JR
Director
Transactions
- Award
Option to Purchase Common Stock [2023 Grant]
2023-05-04+7,500→ 7,500 totalExercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying)
Holdings
- 194,313
Common Stock (held in my name or my wife's name)
- 114.833
Common Stock (ROTH IRA)
- 31,698
Common Stock - Fam. Partnership (LR Ent.)
- 30,000(indirect: GP)
Common Stock - Family LP (BFLP)
- 96,000(indirect: GP)
Common Stock - Fam. Partnership (LFLP)
- 7,500
Option to Purchase Common Stock [2019 Grant]
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying) - 5,000
Option to Purchase Common Stock [2020 Grant]
Exercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (5,000 underlying) - 7,500
Option to Purchase Common Stock [2021 Grant]
Exercise: $71.64From: 2022-05-06Exp: 2023-05-05→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2024-05-04→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Documents
Issuer
NATIONAL HEALTHCARE CORP
CIK 0001047335
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001012859
Filing Metadata
- Form type
- 5
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 6:16 PM ET
- Size
- 14.6 KB